Flosonics
Flosonics Medical, founded in 2015 and headquartered in Sudbury, Ontario, Canada, developed FloPatch, a wireless, wearable ultrasound device that provides real-time hemodynamic assessments to improve fluid management decisions in clinical settings.
About Flosonics Medical
Flosonics Medical was founded in 2015 and is headquartered at 56 Walford Road, Sudbury, Ontario, Canada. The company also operates an engineering office at 325 Front Street, 4th floor, Toronto, Ontario, Canada. Flosonics Medical focuses on improving patient care and the practice of medicine through technology-enabled solutions and ground-breaking clinical research.
FloPatch Wireless Wearable Ultrasound
FloPatch is the first wireless, wearable ultrasound device developed by Flosonics Medical. It provides real-time hemodynamic assessments to clinicians, reporting carotid arterial pulse metrics in seconds and offering insights into cardiac performance. Designed to enhance fluid management decisions, FloPatch helps optimize fluid resuscitation and prevents the administration of harmful and ineffective IV fluids. The device features a user-friendly app that displays a real-time trace of arterial blood velocity and provides key metrics like Corrected Flow Time (FTc) and Velocity Time Integral (VTI).
FDA Clearance and Availability
FloPatch gained regulatory clearance from the FDA in March 2020 under 510(k) number K200337. It is indicated for the non-invasive assessment of blood flow in the carotid artery and operates in Continuous Wave (CW) mode. FloPatch is available by prescription only and intended for use by trained healthcare providers.
Funding and Growth
Flosonics Medical secured $20 million USD in Series C funding led by New Leaf Venture Partners to accelerate its growth. This funding enables the company to further develop and expand its technology offerings, including the FloPatch system.
Industry Recognition and Implementation
Flosonics Medical received the Rising Star award at the 5th Annual Digital Health Hub Foundation Awards hosted at HLTH. Additionally, Riverside University Health System implemented FloPatch to enhance precision fluid management in sepsis care, and El Camino Health was the first to adopt the FloPatch advanced ultrasound technology for sepsis management.